Sign up to save your podcasts
Or
Share Making Sense of Weight-Loss Drugs’ Cost and Coverage
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Making Sense of Weight-Loss Drugs’ Cost and Coverage
GLP-1s like Ozempic and Wegovy are no longer in short supply, yet they still can cost more than $1,000 a month out of pocket. Wall Street Journal contributor Cheryl Winokur Munk joins host Callum Borchers to dig into why some people pay much more for weight-loss drugs than others.
Sign up for the WSJ's free Markets A.M. newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By The Wall Street Journal
4
16511,651 ratings
GLP-1s like Ozempic and Wegovy are no longer in short supply, yet they still can cost more than $1,000 a month out of pocket. Wall Street Journal contributor Cheryl Winokur Munk joins host Callum Borchers to dig into why some people pay much more for weight-loss drugs than others.
Sign up for the WSJ's free Markets A.M. newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like WSJ Your Money Briefing
View all
WSJ Tech News Briefing
1,644 Listeners
WSJ What’s News
4,320 Listeners
Investing Insights
493 Listeners
Motley Fool Money
3,177 Listeners
Bloomberg Intelligence
405 Listeners
Bloomberg Businessweek
443 Listeners
WSJ Opinion: Potomac Watch
2,800 Listeners
WSJ Minute Briefing
661 Listeners
Bold Names
1,458 Listeners
Wall Street Breakfast
1,016 Listeners
Thoughts on the Market
1,277 Listeners
The Journal.
5,955 Listeners
Barron's Streetwise
1,543 Listeners
Barron's Live
198 Listeners
Bad Bets
1,321 Listeners
WSJ Opinion: Free Expression
593 Listeners
As We Work
152 Listeners
WSJ's Take On the Week
126 Listeners